IR

JP EN

About Us
About Us CEO Message Mission&Vision Regenerative Medicine Business Environment Leadership Company Profile
SanBio’s Strengths
SanBio’s Strengths SB623 Pipeline Delivering medical care
to a large number
of patients Large-scale Production
Technology World-Leading
Development Team
Media Inquiries
Medical institutions
and practitioners
Patients and
their families

About Us

About Us

Strengths

SanBio’s Strengths

R&D
- SB623
- Pipeline
Technology

News

NEWS

News Release

2021.01.05

Publication of STEMTRA Phase 2 Interim Analysis for SB623 in Neurology

News

Publication of STEMTRA Phase 2 Interim Analysis for SB623 in Neurology

PRESS

Media Inquiries

IR

Shareholders and
investors

PATIENT / GENERAL

Patients and
their families

Under construction
(release date not yet determined)

MEDICAL PERSONNEL

Medical institutions
and practitioners

Under construction
(release date not yet determined)

CEO Message
Mission&Vision
Regenerative Medicine
Business Environment
Leadership
Company Profile

SanBio’s Strengths

R&D
- SB623
- Pipeline
Technology

Media Inquiries

Copyright© SanBio Co,Ltd. 2020. All Rights Reserved.